Global Romiplostim Market Size, Status and Forecast 2024-2031

Report ID: 917521 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Romiplostim Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 250 μg/0.5 mL
        1.2.3 500 μg/1 mL
    1.3 Market by Application
        1.3.1 Global Romiplostim Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Adults
        1.3.3 Pediatric patients
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Romiplostim Market Perspective (2016-2027)
    2.2 Romiplostim Growth Trends by Regions
        2.2.1 Romiplostim Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Romiplostim Historic Market Share by Regions (2016-2021)
        2.2.3 Romiplostim Forecasted Market Size by Regions (2022-2027)
    2.3 Romiplostim Industry Dynamic
        2.3.1 Romiplostim Market Trends
        2.3.2 Romiplostim Market Drivers
        2.3.3 Romiplostim Market Challenges
        2.3.4 Romiplostim Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Romiplostim Players by Revenue
        3.1.1 Global Top Romiplostim Players by Revenue (2016-2021)
        3.1.2 Global Romiplostim Revenue Market Share by Players (2016-2021)
    3.2 Global Romiplostim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Romiplostim Revenue
    3.4 Global Romiplostim Market Concentration Ratio
        3.4.1 Global Romiplostim Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Romiplostim Revenue in 2020
    3.5 Romiplostim Key Players Head office and Area Served
    3.6 Key Players Romiplostim Product Solution and Service
    3.7 Date of Enter into Romiplostim Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Romiplostim Breakdown Data by Type
    4.1 Global Romiplostim Historic Market Size by Type (2016-2021)
    4.2 Global Romiplostim Forecasted Market Size by Type (2022-2027)

5 Romiplostim Breakdown Data by Application
    5.1 Global Romiplostim Historic Market Size by Application (2016-2021)
    5.2 Global Romiplostim Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Romiplostim Market Size (2016-2027)
    6.2 North America Romiplostim Market Size by Type
        6.2.1 North America Romiplostim Market Size by Type (2016-2021)
        6.2.2 North America Romiplostim Market Size by Type (2022-2027)
        6.2.3 North America Romiplostim Market Size by Type (2016-2027)
    6.3 North America Romiplostim Market Size by Application
        6.3.1 North America Romiplostim Market Size by Application (2016-2021)
        6.3.2 North America Romiplostim Market Size by Application (2022-2027)
        6.3.3 North America Romiplostim Market Size by Application (2016-2027)
    6.4 North America Romiplostim Market Size by Country
        6.4.1 North America Romiplostim Market Size by Country (2016-2021)
        6.4.2 North America Romiplostim Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Romiplostim Market Size (2016-2027)
    7.2 Europe Romiplostim Market Size by Type
        7.2.1 Europe Romiplostim Market Size by Type (2016-2021)
        7.2.2 Europe Romiplostim Market Size by Type (2022-2027)
        7.2.3 Europe Romiplostim Market Size by Type (2016-2027)
    7.3 Europe Romiplostim Market Size by Application
        7.3.1 Europe Romiplostim Market Size by Application (2016-2021)
        7.3.2 Europe Romiplostim Market Size by Application (2022-2027)
        7.3.3 Europe Romiplostim Market Size by Application (2016-2027)
    7.4 Europe Romiplostim Market Size by Country
        7.4.1 Europe Romiplostim Market Size by Country (2016-2021)
        7.4.2 Europe Romiplostim Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Romiplostim Market Size (2016-2027)
    8.2 Asia-Pacific Romiplostim Market Size by Type
        8.2.1 Asia-Pacific Romiplostim Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Romiplostim Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Romiplostim Market Size by Type (2016-2027)
    8.3 Asia-Pacific Romiplostim Market Size by Application
        8.3.1 Asia-Pacific Romiplostim Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Romiplostim Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Romiplostim Market Size by Application (2016-2027)
    8.4 Asia-Pacific Romiplostim Market Size by Region
        8.4.1 Asia-Pacific Romiplostim Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Romiplostim Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Romiplostim Market Size (2016-2027)
    9.2 Latin America Romiplostim Market Size by Type
        9.2.1 Latin America Romiplostim Market Size by Type (2016-2021)
        9.2.2 Latin America Romiplostim Market Size by Type (2022-2027)
        9.2.3 Latin America Romiplostim Market Size by Type (2016-2027)
    9.3 Latin America Romiplostim Market Size by Application
        9.3.1 Latin America Romiplostim Market Size by Application (2016-2021)
        9.3.2 Latin America Romiplostim Market Size by Application (2022-2027)
        9.3.3 Latin America Romiplostim Market Size by Application (2016-2027)
    9.4 Latin America Romiplostim Market Size by Country
        9.4.1 Latin America Romiplostim Market Size by Country (2016-2021)
        9.4.2 Latin America Romiplostim Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Romiplostim Market Size (2016-2027)
    10.2 Middle East & Africa Romiplostim Market Size by Type
        10.2.1 Middle East & Africa Romiplostim Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Romiplostim Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Romiplostim Market Size by Type (2016-2027)
    10.3 Middle East & Africa Romiplostim Market Size by Application
        10.3.1 Middle East & Africa Romiplostim Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Romiplostim Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Romiplostim Market Size by Application (2016-2027)
    10.4 Middle East & Africa Romiplostim Market Size by Country
        10.4.1 Middle East & Africa Romiplostim Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Romiplostim Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AMGEN
        11.1.1 AMGEN Company Details
        11.1.2 AMGEN Business Overview
        11.1.3 AMGEN Romiplostim Introduction
        11.1.4 AMGEN Revenue in Romiplostim Business (2016-2021)
        11.1.5 AMGEN Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Romiplostim Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 250 μg/0.5 mL
    Table 3. Key Players of 500 μg/1 mL
    Table 4. Global Romiplostim Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Romiplostim Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Romiplostim Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Romiplostim Market Share by Regions (2016-2021)
    Table 8. Global Romiplostim Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Romiplostim Market Share by Regions (2022-2027)
    Table 10. Romiplostim Market Trends
    Table 11. Romiplostim Market Drivers
    Table 12. Romiplostim Market Challenges
    Table 13. Romiplostim Market Restraints
    Table 14. Global Romiplostim Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Romiplostim Market Share by Players (2016-2021)
    Table 16. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2020)
    Table 17. Ranking of Global Top Romiplostim Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Romiplostim Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Romiplostim Product Solution and Service
    Table 21. Date of Enter into Romiplostim Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Romiplostim Revenue Market Share by Type (2016-2021)
    Table 25. Global Romiplostim Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Romiplostim Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Romiplostim Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Romiplostim Revenue Market Share by Application (2016-2021)
    Table 29. Global Romiplostim Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Romiplostim Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Romiplostim Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Romiplostim Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Romiplostim Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Romiplostim Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Romiplostim Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Romiplostim Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Romiplostim Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Romiplostim Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Romiplostim Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Romiplostim Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Romiplostim Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Romiplostim Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Romiplostim Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Romiplostim Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Romiplostim Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Romiplostim Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Romiplostim Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Romiplostim Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Romiplostim Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Romiplostim Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Romiplostim Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Romiplostim Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Romiplostim Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Romiplostim Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Romiplostim Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Romiplostim Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. AMGEN Company Details
    Table 62. AMGEN Business Overview
    Table 63. AMGEN Romiplostim Product
    Table 64. AMGEN Revenue in Romiplostim Business (2016-2021) & (US$ Million)
    Table 65. AMGEN Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Romiplostim Market Share by Type: 2020 VS 2027
    Figure 2. 250 μg/0.5 mL Features
    Figure 3. 500 μg/1 mL Features
    Figure 4. Global Romiplostim Market Share by Application: 2020 VS 2027
    Figure 5. Adults Case Studies
    Figure 6. Pediatric patients Case Studies
    Figure 7. Romiplostim Report Years Considered
    Figure 8. Global Romiplostim Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Romiplostim Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Romiplostim Market Share by Regions: 2020 VS 2027
    Figure 11. Global Romiplostim Market Share by Regions (2022-2027)
    Figure 12. Global Romiplostim Market Share by Players in 2020
    Figure 13. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Romiplostim Revenue in 2020
    Figure 15. Global Romiplostim Revenue Market Share by Type (2016-2021)
    Figure 16. Global Romiplostim Revenue Market Share by Type (2022-2027)
    Figure 17. North America Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Romiplostim Market Share by Type (2016-2027)
    Figure 19. North America Romiplostim Market Share by Application (2016-2027)
    Figure 20. North America Romiplostim Market Share by Country (2016-2027)
    Figure 21. United States Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Romiplostim Market Share by Type (2016-2027)
    Figure 25. Europe Romiplostim Market Share by Application (2016-2027)
    Figure 26. Europe Romiplostim Market Share by Country (2016-2027)
    Figure 27. Germany Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Romiplostim Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Romiplostim Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Romiplostim Market Share by Region (2016-2027)
    Figure 37. China Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Romiplostim Market Share by Type (2016-2027)
    Figure 45. Latin America Romiplostim Market Share by Application (2016-2027)
    Figure 46. Latin America Romiplostim Market Share by Country (2016-2027)
    Figure 47. Mexico Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Romiplostim Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Romiplostim Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Romiplostim Market Share by Country (2016-2027)
    Figure 53. Turkey Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. AMGEN Revenue Growth Rate in Romiplostim Business (2016-2021)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AMGEN
Frequently Asked Questions
Romiplostim report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Romiplostim report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Romiplostim report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Azelastine

Azelastine is a potent, second-generation, selective, histamine antagonist (histamine-H1-recep ... Read More

Tetrabenazine

Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders.  ... Read More